Virtual Lymphoma Rounds: Washington, DC – March 22, 2022
Time: 7:00 PM – 8:30 PM ET
Time: 7:00 PM – 8:30 PM ET
The Lymphoma Research Foundation (LRF) announces Requests for Proposals (RFP) on a regular basis each year.
The Lymphoma Research Foundation (LRF) is proud to welcome Ann S. LaCasce, MD, MMSc as Chair of its Scientific Advisory Board (SAB).
7th Translational Research ConferenceLymphoid MalignanciesOctober 20-22, 2023 – Estoril, Portugal #ESHLYMPHOID2023 Chairs: Michael Hallek, Georg Lenz, Laurie Sehn, Louis Staudt REGISTRATION & ABSTRACT SUBMISSION ARE…
Chimeric antigen receptor (CAR) T-cell therapy has become a life-saving treatment option for many people with large B-cell lymphoma. Some patients do not respond to…
On June 15, 2023 the U.S. Food and Drug Administration (FDA) announced it has approved glofitamab-gxbm (Columvi, Genentech, Inc.) for relapsed or
The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and…
The Lymphoma Walk is a Team LRF hosted community fundraising event where survivors, caregivers, family, friends, and supporters join together to walk in honor and…
The Lymphoma Workshop provides the latest information about lymphoma, current treatment options and support issues to members of the lymphoma community.
Immunotherapy refers to treatments that interact with the immune system. Some immunotherapy drugs recognize unique protein on the surface of lymphoma cells.
LRF offers a wide range of support services, educational programs and free publications for people with lymphoma and their loved ones.